Publications en collaboration avec des chercheurs de Institute of Oncology Ljubljana (3)

2022

  1. Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population (Breast Cancer Research and Treatment, (2021), 189, 3, (689-699), 10.1007/s10549-021-06334-0)

    Breast Cancer Research and Treatment

2021

  1. Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population

    Breast Cancer Research and Treatment, Vol. 189, Núm. 3, pp. 689-699

2013

  1. The evolving landscape of protein kinases in breast cancer: Clinical implications

    Cancer Treatment Reviews, Vol. 39, Núm. 1, pp. 68-76